CD177 and atherosclerosis: Although our study was not designed to identify or measure the mechanism by which changes in oxLDL or glycated proteins would induce atherogenesis, the cell surface receptor RAGE is thought to be a key mediator.[111] RAGE is induced in blood vessels under these conditions and the soluble form of RAGE that is secreted is increased in patients with severe atherosclerosis and abnormal protein glycation.